We read with interest the article published entitled "Contrast-Induced Nephropathy and Long-Term Mortality After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction." 1 According to this study, 1 among patients with acute myocardial infarction (AMI), contrast-induced nephropathy (CIN) is an independent predictor of long-term mortality in patients undergoing primary percutaneous coronary intervention (PCI), irrespective of left ventricular ejection fraction (LVEF) and abnormal hemodynamics. 1 We think that the development of CIN in AMI patients with preserved left ventricular function identifies a subset of higher risk patients who are older, hypertensive, with more baseline renal insufficiency, inflammatory activation, and diastolic dysfunction. In addition, previous studies have shown that anemia, elevated C-reactive protein, and admission hyperglycemia increases the risk of CIN in various patient populations. [2] [3] [4] [5] Some studies demonstrated that among AMI patients with preserved LVEF (>45%) submitted to primary PCI, worsening renal function was associated with increased early death but not with a poorer survival rate at long-term follow-up. 6 We think this study 1 is interesting because the factors contributing to the development of CIN should be evaluated and the prognosis, management, and follow-up of patients developing CIN needs to be clarified.
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